References
- Chan JF , KokKH, ZhuZet al. Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerg Microbes Infect., 9(1), 221–236 (2020).
- Chavda VP , BezbaruahR, DekaK, NongrangL, KalitaT. The Delta and Omicron Variants of SARS-CoV-2: what we know so far. Vaccines (Basel)., 10(11), 1926 (2022).
- Markov PV , GhafariM, BeerMet al. The evolution of SARS-CoV-2. Nat. Rev. Microbiol., 21(6), 361–379 (2023).
- Singh D , YiSV. On the origin and evolution of SARS-CoV-2. Exp. Mol. Med., 53(4), 537–547 (2021).
- Kupferschmidt K , WadmanM. End of COVID-19 emergencies sparks debate. Science, 380(6645), 566–567 (2023).
- Lenharo M . WHO declares end to COVID-19’s emergency phase. Naturehttps://doi.org/10.1038/d41586-023-01559-z (2023) ( Epub ahead of print).
- Bosu S . Omicron, Delta, and Beta, deadliest among SARS-CoV-2 variants: an in silico analysis. A PhD thesis submitted to the Department of Mathematics and Natural Sciences, Brac University (2023). https://dspace.bracu.ac.bd/xmlui/handle/10361/19124?show=full
- Gupta S . Evolution of pathogen virulence: studying the complex interplay of pathogen interactions, virulence and transmission helps us understand how they evolve and spread. EMBO Rep., 24(8), e57611 (2023).
- Dyer O . Covid-19: infections climb globally as EG.5 variant gains ground. BMJ, 382, 1900 (2023).
- Berkley S . Ending the covid-19 pandemic means helping countries to catch-up with vaccination, not giving up. BMJ, 376, o786 (2022).